Heidemarie Abrahamian

2.1k total citations · 1 hit paper
50 papers, 1.4k citations indexed

About

Heidemarie Abrahamian is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Physiology. According to data from OpenAlex, Heidemarie Abrahamian has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 10 papers in Physiology. Recurrent topics in Heidemarie Abrahamian's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Diabetes Management and Education (7 papers). Heidemarie Abrahamian is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Diabetes Management and Education (7 papers). Heidemarie Abrahamian collaborates with scholars based in Austria, Germany and United Kingdom. Heidemarie Abrahamian's co-authors include John Fuller, Nish Chaturvedi, Judith Stephenson, M Keipes, Rudolf Prager, K Irsigler, E. Gabrielian, Hildebert Wagner, Alexander Panossian and Areg Hovhannisyan and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetes.

In The Last Decade

Heidemarie Abrahamian

47 papers receiving 1.3k citations

Hit Papers

Effect of lisinopril on progression of retinopathy in nor... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidemarie Abrahamian Austria 16 480 402 313 228 209 50 1.4k
Michel L. Hijmering Netherlands 10 108 0.2× 608 1.5× 597 1.9× 494 2.2× 212 1.0× 12 1.6k
Junji Saruwatari Japan 22 230 0.5× 182 0.5× 100 0.3× 76 0.3× 259 1.2× 108 1.4k
Per Reichard Sweden 16 1.2k 2.6× 332 0.8× 156 0.5× 144 0.6× 189 0.9× 23 1.8k
Naohiko Furuyoshi Japan 7 1.8k 3.7× 244 0.6× 289 0.9× 166 0.7× 480 2.3× 11 2.5k
Mohsen Afarideh Iran 23 363 0.8× 175 0.4× 59 0.2× 82 0.4× 240 1.1× 64 1.5k
Jae‐Seung Yun South Korea 22 576 1.2× 324 0.8× 72 0.2× 74 0.3× 186 0.9× 79 1.3k
Giuseppe Cocco Switzerland 19 97 0.2× 727 1.8× 46 0.1× 183 0.8× 230 1.1× 109 1.3k
Chin-Chou Huang Taiwan 18 180 0.4× 305 0.8× 92 0.3× 97 0.4× 160 0.8× 42 1.1k
Helen L. Lutgers Netherlands 28 783 1.6× 357 0.9× 77 0.2× 69 0.3× 219 1.0× 46 2.4k
Yasuo Ohkubo Japan 5 1.8k 3.8× 250 0.6× 111 0.4× 80 0.4× 428 2.0× 8 2.5k

Countries citing papers authored by Heidemarie Abrahamian

Since Specialization
Citations

This map shows the geographic impact of Heidemarie Abrahamian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidemarie Abrahamian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidemarie Abrahamian more than expected).

Fields of papers citing papers by Heidemarie Abrahamian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidemarie Abrahamian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidemarie Abrahamian. The network helps show where Heidemarie Abrahamian may publish in the future.

Co-authorship network of co-authors of Heidemarie Abrahamian

This figure shows the co-authorship network connecting the top 25 collaborators of Heidemarie Abrahamian. A scholar is included among the top collaborators of Heidemarie Abrahamian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidemarie Abrahamian. Heidemarie Abrahamian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kautzky‐Willer, Alexandra, Michael Leutner, Heidemarie Abrahamian, et al.. (2023). Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2023). Wiener klinische Wochenschrift. 135(S1). 275–285. 8 indexed citations
2.
Clodi, Martin, Michael Resl, Heidemarie Abrahamian, Bernhard Föger, & Raimund Weitgasser. (2023). Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen (Update 2023). Wiener klinische Wochenschrift. 135(S1). 272–274.
3.
Huber, Joakim, et al.. (2023). Positionspapier: Operation und Diabetes mellitus (Update 2023). Wiener klinische Wochenschrift. 135(S1). 256–271. 6 indexed citations
4.
Clodi, Martin, Michael Resl, Heidemarie Abrahamian, Bernhard Föger, & Raimund Weitgasser. (2019). Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen (Update 2019). Wiener klinische Wochenschrift. 131(S1). 218–220. 3 indexed citations
5.
Kaser, Susanne, Yvonne Winhofer-Stöckl, Lili Kazemi-Shirazi, et al.. (2019). Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2019). Wiener klinische Wochenschrift. 131(S1). 16–26. 5 indexed citations
6.
Kautzky‐Willer, Alexandra, Heidemarie Abrahamian, Raimund Weitgasser, et al.. (2016). Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus. Wiener klinische Wochenschrift. 128(S2). 151–158. 8 indexed citations
7.
Abrahamian, Heidemarie, Alexandra Kautzky‐Willer, Peter Fasching, et al.. (2012). Positionspapier: Psychische Erkrankungen und Diabetes mellitus. Wiener klinische Wochenschrift. 124(S2). 107–114. 2 indexed citations
9.
Clodi, Martin, Heidemarie Abrahamian, Heinz Drexel, et al.. (2012). Antihyperglykämische Therapie bei Diabetes mellitus Typ 2. Wiener klinische Wochenschrift. 124(S2). 10–16.
10.
Fasching, Peter, Joakim Huber, Martin Clodi, Heidemarie Abrahamian, & Bernhard Ludvik. (2012). Positionspapier: Operation und Diabetes mellitus. Wiener klinische Wochenschrift. 124(S2). 115–119. 2 indexed citations
11.
12.
Huelsmann, M, Stephanie Neuhold, Guido Strunk, et al.. (2008). NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. European Heart Journal. 29(18). 2259–2264. 64 indexed citations
13.
Abrahamian, Heidemarie, et al.. (2008). Rezidivierende Hypoglykämien und Lactatacidose bei Non-Hodgkin-Lymphom. DMW - Deutsche Medizinische Wochenschrift. 116(38). 1428–1432. 3 indexed citations
14.
Abrahamian, Heidemarie, Georg Endler, Markus Exner, et al.. (2007). Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory Cytokines. Experimental and Clinical Endocrinology & Diabetes. 115(1). 38–41. 35 indexed citations
15.
Abrahamian, Heidemarie & Rudolf Prager. (2002). Senkung der kardiovaskularen Morbiditat und Mortalitat durch antihypertensive Kombinations-therapie bei Patienten mit Typ 2 Diabetes mellitus. Wiener Medizinische Wochenschrift. 152(9-10). 210–214. 1 indexed citations
16.
Abrahamian, Heidemarie. (2001). Hypertonie und Adipositas. Journal für Kardiologie (Krause & Pachernegg GmbH). 5(2). 7–13. 1 indexed citations
17.
Chaturvedi, Nish, et al.. (1998). Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The Lancet. 351(9095). 28–31. 529 indexed citations breakdown →
19.
Abrahamian, Heidemarie, et al.. (1994). [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].. PubMed. 106(5). 136–40. 3 indexed citations
20.
Wanke, T., Heidemarie Abrahamian, Heinz Lahrmann, et al.. (1993). No Effect of Naloxone on Ventilatory Response to Progressive Hypercapnia in IDDM Patients. Diabetes. 42(2). 282–287. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026